Furosemide

Product NDC: 42291-469
11-digit product format: 422910469
Labeler code: 42291
Product ID: 42291-469_485d7945-6751-e159-e063-6294a90a27ce
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: furosemide
Dosage form: TABLET
Route: ORAL
Labeler: AvKARE
Application: ANDA076796
Marketing category: ANDA
Marketing start: 2022-01-04
Substance: FUROSEMIDE
Active strength: 40 mg/1
Pharmacologic classes: Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]
NDC exclude flag: No
Listing certified through: 2027-12-31
Current FDA listing: Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 3 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	Approval date
A076796-001	FUROSEMIDE	FUROSEMIDE	20MG	TABLET / ORAL	AB	2004-03-26
A076796-002	FUROSEMIDE	FUROSEMIDE	40MG	TABLET / ORAL	AB	2004-03-26
A076796-003	FUROSEMIDE	FUROSEMIDE	80MG	TABLET / ORAL	AB	2004-03-26

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 3 matching rows.

Application-product, TE code table
Application-product	TE code
A076796-001	AB
A076796-002	AB
A076796-003	AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 4 · 123 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	Approval date	Source SHA-256
2026-02-19 14:30 UTC	2026-02	A076796-001	FUROSEMIDE	20MG	TABLET / ORAL	AB	2004-03-26	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A076796-002	FUROSEMIDE	40MG	TABLET / ORAL	AB	2004-03-26	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A076796-003	FUROSEMIDE	80MG	TABLET / ORAL	AB	2004-03-26	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A076796-001	FUROSEMIDE	20MG	TABLET / ORAL	AB	2004-03-26	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A076796-002	FUROSEMIDE	40MG	TABLET / ORAL	AB	2004-03-26	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A076796-003	FUROSEMIDE	80MG	TABLET / ORAL	AB	2004-03-26	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A076796-001	FUROSEMIDE	20MG	TABLET / ORAL	AB	2004-03-26	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A076796-002	FUROSEMIDE	40MG	TABLET / ORAL	AB	2004-03-26	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A076796-003	FUROSEMIDE	80MG	TABLET / ORAL	AB	2004-03-26	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A076796-001	FUROSEMIDE	20MG	TABLET / ORAL	AB	2004-03-26	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A076796-002	FUROSEMIDE	40MG	TABLET / ORAL	AB	2004-03-26	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A076796-003	FUROSEMIDE	80MG	TABLET / ORAL	AB	2004-03-26	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A076796-001	FUROSEMIDE	20MG	TABLET / ORAL	AB	2004-03-26	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A076796-002	FUROSEMIDE	40MG	TABLET / ORAL	AB	2004-03-26	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A076796-003	FUROSEMIDE	80MG	TABLET / ORAL	AB	2004-03-26	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A076796-001	FUROSEMIDE	20MG	TABLET / ORAL	AB	2004-03-26	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A076796-002	FUROSEMIDE	40MG	TABLET / ORAL	AB	2004-03-26	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A076796-003	FUROSEMIDE	80MG	TABLET / ORAL	AB	2004-03-26	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A076796-001	FUROSEMIDE	20MG	TABLET / ORAL	AB	2004-03-26	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A076796-002	FUROSEMIDE	40MG	TABLET / ORAL	AB	2004-03-26	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A076796-003	FUROSEMIDE	80MG	TABLET / ORAL	AB	2004-03-26	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A076796-001	FUROSEMIDE	20MG	TABLET / ORAL	AB	2004-03-26	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A076796-002	FUROSEMIDE	40MG	TABLET / ORAL	AB	2004-03-26	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A076796-003	FUROSEMIDE	80MG	TABLET / ORAL	AB	2004-03-26	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A076796-001	FUROSEMIDE	20MG	TABLET / ORAL	AB	2004-03-26	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A076796-002	FUROSEMIDE	40MG	TABLET / ORAL	AB	2004-03-26	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A076796-003	FUROSEMIDE	80MG	TABLET / ORAL	AB	2004-03-26	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A076796-001	FUROSEMIDE	20MG	TABLET / ORAL	AB	2004-03-26	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A076796-002	FUROSEMIDE	40MG	TABLET / ORAL	AB	2004-03-26	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A076796-003	FUROSEMIDE	80MG	TABLET / ORAL	AB	2004-03-26	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A076796-001	FUROSEMIDE	20MG	TABLET / ORAL	AB	2004-03-26	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A076796-002	FUROSEMIDE	40MG	TABLET / ORAL	AB	2004-03-26	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A076796-003	FUROSEMIDE	80MG	TABLET / ORAL	AB	2004-03-26	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A076796-001	FUROSEMIDE	20MG	TABLET / ORAL	AB	2004-03-26	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A076796-002	FUROSEMIDE	40MG	TABLET / ORAL	AB	2004-03-26	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A076796-003	FUROSEMIDE	80MG	TABLET / ORAL	AB	2004-03-26	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A076796-001	FUROSEMIDE	20MG	TABLET / ORAL	AB	2004-03-26	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A076796-002	FUROSEMIDE	40MG	TABLET / ORAL	AB	2004-03-26	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A076796-003	FUROSEMIDE	80MG	TABLET / ORAL	AB	2004-03-26	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A076796-001	FUROSEMIDE	20MG	TABLET / ORAL	AB	2004-03-26	`8072bd15b7f6…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 4 · 123 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-02-19 14:30 UTC	2026-02	A076796-001	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A076796-002	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A076796-003	AB	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A076796-001	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A076796-002	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A076796-003	AB	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A076796-001	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A076796-002	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A076796-003	AB	1	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A076796-001	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A076796-002	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A076796-003	AB	1	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A076796-001	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A076796-002	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A076796-003	AB	1	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A076796-001	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A076796-002	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A076796-003	AB	1	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A076796-001	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A076796-002	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A076796-003	AB	1	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A076796-001	AB	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A076796-002	AB	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A076796-003	AB	1	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A076796-001	AB	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A076796-002	AB	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A076796-003	AB	1	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A076796-001	AB	1	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A076796-002	AB	1	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A076796-003	AB	1	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A076796-001	AB	1	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A076796-002	AB	1	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A076796-003	AB	1	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A076796-001	AB	1	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A076796-002	AB	1	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A076796-003	AB	1	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A076796-001	AB	1	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A076796-002	AB	1	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A076796-003	AB	1	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A076796-001	AB	1	`8072bd15b7f6…`

Additional Listing Data#

Finished product: Yes
Brand name base: Furosemide
Listing expiration: 2027-12-31

Active Ingredients#

Ingredient, Strength table
Ingredient	Strength
FUROSEMIDE	40 mg/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
7LXU5N7ZO5	Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 3 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
197732	Internal RxNorm lookup
310429	Internal RxNorm lookup
313988	Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
d4c532be-1f3f-60d3-e053-2995a90a98be	Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
d80d3aff-3a63-4d7b-a2be-fd9388b04330	Product name	9	20250806
9061e89f-9c86-4196-b34b-886fc1673cc4	Product name	1	20140821

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	SPL version
42291-469-01	Furosemide	100 in 1 BOTTLE	TABLET	100	3
42291-469-10	Furosemide	1000 in 1 BOTTLE	TABLET	1000	3
42291-469-90	Furosemide	90 in 1 BOTTLE	TABLET	90	3

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
42291-469-01	EA - Each	42291-469	5871547a-09e5-431a-ac5f-d37f4dde019b	1	2022-02-07
42291-469-10	EA - Each	42291-469	16367696-4c75-4032-b16f-f7c11f2aa402	1	2022-02-07
42291-469-90	EA - Each	42291-469	8a189db5-ed07-495f-b8bb-c0e1a09d015d	1	2022-02-07

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
42291-469	FUROSEMIDE TABLET [AVKARE]	2	Current NDC, Legacy NDC, 3 package rows	20240110_d4c532be-1f3f-60d3-e053-2995a90a98be.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 2 · 30 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Furosemide	FUROSEMIDE	REMEDYREPACK INC.	3d312ab0-589c-427b-84da-18887244bfc9	2026-07-15	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 076796 application number: ANDA076796
Furosemide	FUROSEMIDE	Cardinal Health 107, LLC	2a5bcf50-6d63-463a-915e-a72ea2e5f131	2026-06-18	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 076796 application number: ANDA076796
Furosemide	FUROSEMIDE	Major Pharmaceuticals	6be1addd-a811-47fc-8650-6870d661c234	2026-05-26	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 076796 application number: ANDA076796
Furosemide	FUROSEMIDE	REMEDYREPACK INC.	7181e528-c862-4dd7-8446-9011e4c7312a	2026-04-23	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 076796 application number: ANDA076796
Furosemide	FUROSEMIDE	NuCare Pharmaceuticals,Inc.	bd45c963-a413-e9a1-e053-2a95a90a1438	2026-02-19	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 076796 application number: ANDA076796
Furosemide	FUROSEMIDE	AvKARE	d4c532be-1f3f-60d3-e053-2995a90a98be	2026-01-14	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 076796 application number: ANDA076796 ndc (product): 42291-469
Furosemide	FUROSEMIDE	Northwind Health Company, LLC	f2b920b2-f8b3-1e6e-e053-2a95a90ae153	2026-01-01	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 076796 application number: ANDA076796
Furosemide	FUROSEMIDE	PD-Rx Pharmaceuticals, Inc.	48d8f490-e9d1-4c95-ab2f-414d3f4a9df4	2025-08-18	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 076796 application number: ANDA076796
Furosemide	FUROSEMIDE	PD-Rx Pharmaceuticals, Inc.	c24489c3-65e0-44e3-a50a-8bb0672e8821	2025-08-15	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 076796 application number: ANDA076796
Furosemide	FUROSEMIDE	PD-Rx Pharmaceuticals, Inc.	52e75604-5766-40e8-a13a-8c449e06ebda	2025-08-15	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 076796 application number: ANDA076796
Furosemide	FUROSEMIDE	PD-Rx Pharmaceuticals, Inc.	12137a90-fb35-45d7-8984-0b04793d3e34	2025-08-15	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 076796 application number: ANDA076796
Furosemide	FUROSEMIDE	PD-Rx Pharmaceuticals, Inc.	3ba730ab-90d4-478a-80b3-1ea3edb03e4d	2025-07-15	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 076796 application number: ANDA076796
Furosemide	FUROSEMIDE	Solco Healthcare LLC	6a0fb397-63ae-4fce-bddf-16a91b1b7a2f	2025-06-18	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 076796 application number: ANDA076796
Furosemide	FUROSEMIDE	NCS HealthCare of KY, LLC dba Vangard Labs	114f4f4f-536a-4658-8fd0-2dd8c029b19a	2024-09-17	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 076796 application number: ANDA076796
Furosemide	FUROSEMIDE	Bryant Ranch Prepack	25c0aded-ffcd-4145-a48c-76c5fb220f61	2024-08-23	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 076796 application number: ANDA076796
Furosemide	FUROSEMIDE	NuCare Pharmaceuticals,Inc.	6cbf3834-0433-4dc0-e053-2a91aa0a8f8a	2024-06-10	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 076796 application number: ANDA076796
Furosemide	FUROSEMIDE	NuCare Pharmaceuticals,Inc.	7316929d-413a-e78f-e053-2a91aa0a417e	2024-06-10	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 076796 application number: ANDA076796
Furosemide	FUROSEMIDE	NuCare Pharmaceuticals,Inc.	73e5c8f3-32f8-114c-e053-2a91aa0ab500	2024-06-10	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 076796 application number: ANDA076796
Furosemide	FUROSEMIDE	Aphena Pharma Solutions - Tennessee, LLC	4b3e2e13-a657-4da5-b536-8ae0a26812e0	2024-06-03	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 076796 application number: ANDA076796
Furosemide	FUROSEMIDE	Bryant Ranch Prepack	3b028a3c-102a-40f1-820e-b187ff1e1803	2024-03-22	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 076796 application number: ANDA076796

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
7LXU5N7ZO5	FUROSEMIDE	54-31-9	FUROSEMIDE

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
310429	furosemide 20 MG Oral Tablet	PSN	d4c532be-1f3f-60d3-e053-2995a90a98be	3
313988	furosemide 40 MG Oral Tablet	PSN	d4c532be-1f3f-60d3-e053-2995a90a98be	3
197732	furosemide 80 MG Oral Tablet	PSN	d4c532be-1f3f-60d3-e053-2995a90a98be	3
310429	furosemide 20 MG Oral Tablet	SCD	d4c532be-1f3f-60d3-e053-2995a90a98be	3
313988	furosemide 40 MG Oral Tablet	SCD	d4c532be-1f3f-60d3-e053-2995a90a98be	3
197732	furosemide 80 MG Oral Tablet	SCD	d4c532be-1f3f-60d3-e053-2995a90a98be	3
310429	furosemide 20 MG Oral Tablet	PSN	6f124d7d-a19d-4de6-8ea4-719a42eb520b	2
313988	furosemide 40 MG Oral Tablet	PSN	6f124d7d-a19d-4de6-8ea4-719a42eb520b	2
197732	furosemide 80 MG Oral Tablet	PSN	6f124d7d-a19d-4de6-8ea4-719a42eb520b	2
310429	furosemide 20 MG Oral Tablet	SCD	6f124d7d-a19d-4de6-8ea4-719a42eb520b	2
313988	furosemide 40 MG Oral Tablet	SCD	6f124d7d-a19d-4de6-8ea4-719a42eb520b	2
197732	furosemide 80 MG Oral Tablet	SCD	6f124d7d-a19d-4de6-8ea4-719a42eb520b	2

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
42291-469-01	42291046901	100 TABLET in 1 BOTTLE (42291-469-01)	100 tablet	2022-01-04	0000-00-00	No	No	Current
42291-469-10	42291046910	1000 TABLET in 1 BOTTLE (42291-469-10)	1000 tablet	2022-01-04	0000-00-00	No	No	Current
42291-469-90	42291046990	90 TABLET in 1 BOTTLE (42291-469-90)	90 tablet	2022-01-04	0000-00-00	No	No	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
FUROSEMIDE TABLETS, USP	AvKARE	2026-01-14	HUMAN PRESCRIPTION DRUG LABEL	3
FUROSEMIDE TABLETS, USP	Aphena Pharma Solutions - Tennessee, LLC	2022-03-10	HUMAN PRESCRIPTION DRUG LABEL	2